Year archive

MICROBA LIFE SCIENCES LIMITED — 2023 filings

All 88 regulatory filings released by MICROBA LIFE SCIENCES LIMITED (MAP) in 2023, sourced directly from the official regulator.

88 Filings

2023 Period

2023 filings (88)

Filing	Released	Lang
Change of Director's Interest Notice - Jacqueline Fernley 2 pages 288.7KB Regulatory Filings	2023-12-28	English
Notification regarding unquoted securities - MAP 7 pages 31.6KB Regulatory Filings	2023-12-28	English
Successful IBD Phase I Clinical Trial 3 pages 253.0KB Regulatory Filings	2023-12-06	English
Completion of Acquisition of Invivo Clinical Limited 2 pages 147.8KB Regulatory Filings	2023-12-05	English
Application for quotation of securities - MAP 6 pages 28.0KB Regulatory Filings	2023-12-05	English
Cleansing Notice 2 pages 213.0KB Regulatory Filings	2023-12-05	English
Research Agreement Executed with IFF for Allergy Program 2 pages 180.8KB Regulatory Filings	2023-12-03	English
Proposed issue of securities - MAP 5 pages 27.9KB Regulatory Filings	2023-12-03	English
Proposed issue of securities - MAP 5 pages 28.0KB Regulatory Filings	2023-12-03	English
2023 AGM Presentations 27 pages 3.5MB Regulatory Filings	2023-11-29	English
Results of Annual General Meeting 2 pages 206.1KB Regulatory Filings	2023-11-29	English
Change in substantial holding 2 pages 892.2KB Regulatory Filings	2023-11-28	English
Autoimmune Stage 1 Screening Complete with Gingko Bioworks 23 pages 4.9MB Regulatory Filings	2023-11-27	English
Listing Rule 6.22.2 Adjustment to Option Exercise Prices 2 pages 157.9KB Regulatory Filings	2023-11-27	English
Change in substantial holding 5 pages 355.8KB Regulatory Filings	2023-11-27	English
Application for quotation of securities - MAP 6 pages 28.2KB Regulatory Filings	2023-11-22	English
Results of Retail Entitlement Offer 3 pages 210.3KB Regulatory Filings	2023-11-19	English
MAP CEO presents at Bell Potter Healthcare Conference 2023 23 pages 3.4MB Regulatory Filings	2023-11-15	English
Investor Presentation 32 pages 4.7MB Regulatory Filings	2023-11-05	English
Ceasing to be a substantial holder 1 page 39.8KB Regulatory Filings	2023-11-01	English
Change in substantial holding 5 pages 437.9KB Regulatory Filings	2023-10-31	English
Change in substantial holding 4 pages 844.7KB Regulatory Filings	2023-10-31	English
Change of Director's Interest Notice - Pasquale Rombola 2 pages 198.1KB Regulatory Filings	2023-10-30	English
Change of Director's Interest Notice - Prof Ian Frazer 2 pages 199.6KB Regulatory Filings	2023-10-30	English
Change of Director's Interest Notice - Richard Bund 2 pages 196.4KB Regulatory Filings	2023-10-30	English
Application for quotation of securities - MAP 6 pages 27.8KB Regulatory Filings	2023-10-29	English
Letter to Shareholders, Notice of AGM & Proxy Form 48 pages 1.0MB Regulatory Filings	2023-10-29	English
Annual Report to Shareholders 82 pages 4.5MB Regulatory Filings	2023-10-29	English
Retail Offer opens and dispatch of Offer Booklet 121 pages 6.7MB Regulatory Filings	2023-10-25	English
Letter to Ineligible Shareholders 3 pages 160.1KB Regulatory Filings	2023-10-25	English
Fully Underwritten A$20 million Entitlement Offer 8 pages 337.8KB Regulatory Filings	2023-10-22	English
Update - Proposed issue of securities - MAP 7 pages 34.3KB Regulatory Filings	2023-10-22	English
Cleansing Notice under sections 708AA(12) and 708A(9) 5 pages 263.4KB Regulatory Filings	2023-10-22	English
Trading Halt 2 pages 537.2KB Regulatory Filings	2023-10-18	English
Q1 FY24 Quarterly Activities Report & Appendix 4C 12 pages 1.0MB Regulatory Filings	2023-10-18	English
Microba to acquire UK microbiome leader Invivo Clinical 10 pages 319.9KB Regulatory Filings	2023-10-18	English
Invivo Clinical Acquisition and Capital Raising Presentation 49 pages 5.1MB Regulatory Filings	2023-10-18	English
Application for quotation of securities - MAP 7 pages 31.9KB Regulatory Filings	2023-10-18	English
Proposed issue of securities - MAP 7 pages 33.7KB Regulatory Filings	2023-10-18	English
Excluded Information Notice 2 pages 153.1KB Regulatory Filings	2023-10-18	English
Notification to Optionholders 2 pages 171.1KB Regulatory Filings	2023-10-18	English
Cleansing Notice section 708AA(2)(f) & 708A(5)(e) 4 pages 206.0KB Regulatory Filings	2023-10-18	English
Date of AGM and Closing Date for Director Nominations 1 Regulatory Filings	2023-10-11	English
Corporate Governance Statement 14 pages 321.2KB Regulatory Filings	2023-08-29	English
Appendix 4E & Annual Report 84 pages 4.5MB Regulatory Filings	2023-08-29	English
Appendix 4G 13 pages 391.8KB Regulatory Filings	2023-08-29	English
Microba Completes Dosing in Phase I IBD Clinical Trial 2 pages 187.3KB Regulatory Filings	2023-08-24	English
Notification regarding unquoted securities - MAP 8 pages 36.5KB Regulatory Filings	2023-08-03	English
Q4 FY23 Quarterly Activities Report & Appendix 4C 12 pages 518.2KB Regulatory Filings	2023-07-26	English
Q4 FY23 Quarterly Investor Presentation 26 pages 3.7MB Regulatory Filings	2023-07-26	English
Details of Q4 FY23 Quarterly Report, Appendix 4C & Webinar 1 Regulatory Filings	2023-07-24	English
Microba to Present at 17th Bioshares Biotech Summit 26 pages 7.3MB Regulatory Filings	2023-07-23	English
Ceasing to be a substantial holder 1 page 202.6KB Regulatory Filings	2023-07-06	English
First Distribution Agreement Executed with Sonic Healthcare 3 pages 206.7KB Regulatory Filings	2023-07-04	English
Notification of cessation of securities - MAP 4 pages 24.0KB Regulatory Filings	2023-06-29	English
Microba Commences Phase I Clinical Trial for IBD Therapeutic 2 pages 187.2KB Regulatory Filings	2023-06-27	English
MRFF Grant Awarded to QUT, In Collaboration With Microba 2 pages 173.4KB Regulatory Filings	2023-06-26	English
Notification of cessation of securities - MAP 4 pages 24.0KB Regulatory Filings	2023-06-15	English
Appendix 3Z - Final Director's Interest Notice 2 pages 225.4KB Regulatory Filings	2023-06-13	English
Microba receives two AusIndustry Advanced Overseas Findings 1 Regulatory Filings	2023-06-13	English
Director Resignation 1 page 136.3KB Regulatory Filings	2023-06-05	English
Cleansing Notice 1 page 156.8KB Regulatory Filings	2023-05-28	English
Application for quotation of securities - MAP 6 pages 28.1KB Regulatory Filings	2023-05-28	English
Change in substantial holding from TEK 5 pages 291.7KB Regulatory Filings	2023-05-11	English
Change in substantial holding - Tiga Trading Pty Ltd 5 pages 245.7KB Regulatory Filings	2023-05-11	English
Application for quotation of securities - MAP 6 pages 28.6KB Regulatory Filings	2023-05-02	English
Cleansing Notice 1 page 157.4KB Regulatory Filings	2023-05-02	English
Q3 FY23 Quarterly Activities Report & Appendix 4C 11 pages 441.9KB Regulatory Filings	2023-04-19	English
Q3 FY23 Quarterly Investor Presentation 26 pages 3.8MB Regulatory Filings	2023-04-19	English
Details of Q3 FY23 Quarterly Report, Appendix 4C & Webinar 1 Regulatory Filings	2023-04-18	English
Application for quotation of securities - MAP 6 pages 28.0KB Regulatory Filings	2023-04-13	English
Cleansing Notice 1 page 151.9KB Regulatory Filings	2023-04-13	English
SYNLAB Contracts Signed in Poland, Hungary, Romania, Croatia 2 pages 172.7KB Regulatory Filings	2023-04-12	English
Microba Receives Ethics Approval for Phase 1 Clinical Trial 2 pages 175.3KB Regulatory Filings	2023-03-28	English
Release of Securities from Voluntary Escrow 1 page Regulatory Filings	2023-03-27	English
NWR Virtual Healthcare Conference Presentation 25 pages 4.1MB Regulatory Filings	2023-03-20	English
Microba to present at NWR Virtual Investor Conference 1 Regulatory Filings	2023-03-15	English
SYNLAB Agreements Signed in Turkiye and Czech Republic 2 pages 169.2KB Regulatory Filings	2023-03-01	English
Microba Launches Next Generation Healthcare Testing 2 pages 230.7KB Regulatory Filings	2023-02-27	English
H1 FY23 Interim Report 34 pages 8.3MB Regulatory Filings	2023-02-22	English
ShareCafe Small Cap Hidden Gems Presentation 1 page Regulatory Filings	2023-02-08	English
US Distribution Agreement Signed with Luminary Health 2 pages 162.5KB Regulatory Filings	2023-02-06	English
Notification regarding unquoted securities - MAP 7 pages 30.7KB Regulatory Filings	2023-02-01	English
Positive first animal data for Cancer Program 2 pages 283.3KB Regulatory Filings	2023-01-31	English
Results of General Meeting 2 pages 152.1KB Regulatory Filings	2023-01-31	English
Q2 FY23 Quarterly Investor Presentation 20 pages 2.8MB Regulatory Filings	2023-01-30	English
Details of Q2 FY23 Investor Webinar 1 page 180.4KB Regulatory Filings	2023-01-29	English
Q2 FY23 Quarterly Activities Report & Appendix 4C 11 pages 487.7KB Regulatory Filings	2023-01-29	English